613 related articles for article (PubMed ID: 23689808)
1. TH17 cell induction and effects of IL-17A and IL-17F blockade in experimental colitis.
Wedebye Schmidt EG; Larsen HL; Kristensen NN; Poulsen SS; Lynge Pedersen AM; Claesson MH; Pedersen AE
Inflamm Bowel Dis; 2013 Jul; 19(8):1567-76. PubMed ID: 23689808
[TBL] [Abstract][Full Text] [Related]
2. Combined blockade of IL-17A and IL-17F may prevent the development of experimental colitis.
McLean LP; Cross RK; Shea-Donohue T
Immunotherapy; 2013 Sep; 5(9):923-5. PubMed ID: 23998727
[TBL] [Abstract][Full Text] [Related]
3. Neutralizing IL-23 is superior to blocking IL-17 in suppressing intestinal inflammation in a spontaneous murine colitis model.
Wang R; Hasnain SZ; Tong H; Das I; Che-Hao Chen A; Oancea I; Proctor M; Florin TH; Eri RD; McGuckin MA
Inflamm Bowel Dis; 2015 May; 21(5):973-84. PubMed ID: 25803508
[TBL] [Abstract][Full Text] [Related]
4. RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F.
Leppkes M; Becker C; Ivanov II; Hirth S; Wirtz S; Neufert C; Pouly S; Murphy AJ; Valenzuela DM; Yancopoulos GD; Becher B; Littman DR; Neurath MF
Gastroenterology; 2009 Jan; 136(1):257-67. PubMed ID: 18992745
[TBL] [Abstract][Full Text] [Related]
5. Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production.
Feng T; Qin H; Wang L; Benveniste EN; Elson CO; Cong Y
J Immunol; 2011 Jun; 186(11):6313-8. PubMed ID: 21531892
[TBL] [Abstract][Full Text] [Related]
6. KSR1 protects from interleukin-10 deficiency-induced colitis in mice by suppressing T-lymphocyte interferon-γ production.
Goettel JA; Scott Algood HM; Olivares-Villagómez D; Washington MK; Chaturvedi R; Wilson KT; Van Kaer L; Polk DB
Gastroenterology; 2011 Jan; 140(1):265-74. PubMed ID: 20875416
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-12 converts Foxp3+ regulatory T cells to interferon-γ-producing Foxp3+ T cells that inhibit colitis.
Feng T; Cao AT; Weaver CT; Elson CO; Cong Y
Gastroenterology; 2011 Jun; 140(7):2031-43. PubMed ID: 21419767
[TBL] [Abstract][Full Text] [Related]
8. Cytokine expression and the role of Th17 cells in a mouse model of colitis.
He Y; Lin LJ; Zheng CQ; Jin Y; Lin Y
Mol Med Rep; 2012 Dec; 6(6):1438-42. PubMed ID: 23027085
[TBL] [Abstract][Full Text] [Related]
9. Compartmentalized expression of Th1 and Th17 cytokines in pediatric inflammatory bowel diseases.
Verdier J; Begue B; Cerf-Bensussan N; Ruemmele FM
Inflamm Bowel Dis; 2012 Jul; 18(7):1260-6. PubMed ID: 21994045
[TBL] [Abstract][Full Text] [Related]
10. IL-17/IFN-γ interactions regulate intestinal inflammation in TNBS-induced acute colitis.
Jin Y; Lin Y; Lin L; Zheng C
J Interferon Cytokine Res; 2012 Nov; 32(11):548-56. PubMed ID: 23030668
[TBL] [Abstract][Full Text] [Related]
11. Expression of IL-17F is associated with non-pathogenic Th17 cells.
Wanke F; Tang Y; Gronke K; Klebow S; Moos S; Hauptmann J; Shanmugavadivu A; Regen T; Mufazalov IA; Gabriel LA; Reißig S; Diefenbach A; Kurschus FC; Waisman A
J Mol Med (Berl); 2018 Aug; 96(8):819-829. PubMed ID: 29959474
[TBL] [Abstract][Full Text] [Related]
12. Increased IL-17A/IL-17F expression ratio represents the key mucosal T helper/regulatory cell-related gene signature paralleling disease activity in ulcerative colitis.
Iboshi Y; Nakamura K; Fukaura K; Iwasa T; Ogino H; Sumida Y; Ihara E; Akiho H; Harada N; Nakamuta M
J Gastroenterol; 2017 Mar; 52(3):315-326. PubMed ID: 27178567
[TBL] [Abstract][Full Text] [Related]
13. Tbet or Continued RORγt Expression Is Not Required for Th17-Associated Immunopathology.
Brucklacher-Waldert V; Ferreira C; Innocentin S; Kamdar S; Withers DR; Kullberg MC; Veldhoen M
J Immunol; 2016 Jun; 196(12):4893-904. PubMed ID: 27183623
[TBL] [Abstract][Full Text] [Related]
14. mTOR Inhibition Attenuates Dextran Sulfate Sodium-Induced Colitis by Suppressing T Cell Proliferation and Balancing TH1/TH17/Treg Profile.
Hu S; Chen M; Wang Y; Wang Z; Pei Y; Fan R; Liu X; Wang L; Zhou J; Zheng S; Zhang T; Lin Y; Zhang M; Tao R; Zhong J
PLoS One; 2016; 11(4):e0154564. PubMed ID: 27128484
[TBL] [Abstract][Full Text] [Related]
15. Th17-cell plasticity in Helicobacter hepaticus-induced intestinal inflammation.
Morrison PJ; Bending D; Fouser LA; Wright JF; Stockinger B; Cooke A; Kullberg MC
Mucosal Immunol; 2013 Nov; 6(6):1143-56. PubMed ID: 23462910
[TBL] [Abstract][Full Text] [Related]
16. Delivery of IL-12p40 ameliorates DSS-induced colitis by suppressing IL-17A expression and inflammation in the intestinal mucosa.
Kim DJ; Kim KS; Song MY; Seo SH; Kim SJ; Yang BG; Jang MH; Sung YC
Clin Immunol; 2012 Sep; 144(3):190-9. PubMed ID: 22836084
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice.
Elson CO; Cong Y; Weaver CT; Schoeb TR; McClanahan TK; Fick RB; Kastelein RA
Gastroenterology; 2007 Jun; 132(7):2359-70. PubMed ID: 17570211
[TBL] [Abstract][Full Text] [Related]
18. Presence, function, and regulation of IL-17F-expressing human CD4
Burns LA; Maroof A; Marshall D; Steel KJA; Lalnunhlimi S; Cole S; Catrina A; Kirkham B; Taams LS
Eur J Immunol; 2020 Apr; 50(4):568-580. PubMed ID: 31850514
[TBL] [Abstract][Full Text] [Related]
19. Increased CD4
Ma YH; Zhang J; Chen X; Xie YF; Pang YH; Liu XJ
World J Gastroenterol; 2016 Nov; 22(42):9356-9367. PubMed ID: 27895423
[TBL] [Abstract][Full Text] [Related]
20. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
